humanitarian Archived signal

Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New Oct 20, 2026 · 10:45 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 5, Status: Authorised10:45 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 5, Status: Authorised10:45 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date of authorisation: 13/11/2013, Revision: 17, Status: Authorised10:44 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date of authorisation: 13/11/2013, Revision: 17, Status: Authorised10:44 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Tookad, padeliporfin, Date of authorisation: 10/11/2017, Revision: 6, Status: Authorised10:43 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Tookad, padeliporfin, Date of authorisation: 10/11/2017, Revision: 6, Status: Authorised10:43 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Jevtana, cabazitaxel, Date of authorisation: 17/03/2011, Revision: 25, Status: Authorised10:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Jevtana, cabazitaxel, Date of authorisation: 17/03/2011, Revision: 25, Status: Authorised10:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Firmagon, degarelix, Date of authorisation: 17/02/2009, Revision: 19, Status: Authorised10:41 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Firmagon, degarelix, Date of authorisation: 17/02/2009, Revision: 19, Status: Authorised10:41 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 6, Status: Authorised10:40 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 6, Status: Authorised10:40 UTC

INCIDENT EVOLUTION

1 recorded state

Oct 20 · 11:02 UTC

Signal first indexedP2 · 99% quality · 2 sources

Explore this day in the archive →